BioWorld

Nov. 25, 2002

View Archived Issues

Myriad Genetics Raises $57.3M Through Stock Sale From Shelf

About two weeks after filing a shelf registration statement to sell up to $250 million in securities, Myriad Genetics Inc. is raising $57.3 million through a pursuant offering of 3 million shares of stock. (BioWorld Today) Read More

Altea Series B Raises $17M For Trials Of Lead Products

Read More

Vaccine Against Cervical Cancer Racked Up 100 Percent Efficacy In Placebo-Controlled Human Trial

Read More

From 'Position Of Strength,' QLT Reduces Staff 18 Percent

Read More

Other News To Note

Read More

Appointments And Announcements

Read More

Correction

Read More